Patent classifications
A61K36/07
IDENTIFICATION AND SELECTION OF A PLANT STARTING MATERIAL OF A PLANT CHONDROITIN SULFATE AND HYALURONIC ACID, AND TRANSFORMATION OF SUCH PLANT STARTING MATERIAL TO OBTAIN INGREDIENTS FOR USE IN FOODS, SUPPLEMENTS, MEDICAL DEVICES OR DRUGS
Process is described for extraction from a plant starting material, such as a fungus, for the preparation of a mixture (m) of at least one glycosaminoglycan selected from: (a) hyaluronic acid or a salt thereof (HA) having a weight average molecular weight from 10 kDa to 600 kDa; (b) chondroitin or chondroitin sulfate or a salt thereof (CS) having a weight average molecular weight comprised from 3 kDa to 50 kDa; and (c) a combination of (a) and (b).
IDENTIFICATION AND SELECTION OF A PLANT STARTING MATERIAL OF A PLANT CHONDROITIN SULFATE AND HYALURONIC ACID, AND TRANSFORMATION OF SUCH PLANT STARTING MATERIAL TO OBTAIN INGREDIENTS FOR USE IN FOODS, SUPPLEMENTS, MEDICAL DEVICES OR DRUGS
Process is described for extraction from a plant starting material, such as a fungus, for the preparation of a mixture (m) of at least one glycosaminoglycan selected from: (a) hyaluronic acid or a salt thereof (HA) having a weight average molecular weight from 10 kDa to 600 kDa; (b) chondroitin or chondroitin sulfate or a salt thereof (CS) having a weight average molecular weight comprised from 3 kDa to 50 kDa; and (c) a combination of (a) and (b).
A PREPARATION METHOD OF ANTRODIA CINNAMOMEA WATER-INSOLUBLE DIETARY FIBER
A preparation method of Antrodia cinnamomea water-insoluble dietary fiber. After ethanol and water extraction, Antrodia cinnamomea wastes are dried and superfine-comminuted to obtain Antrodia cinnamomea waste powder. The waste powder treated with NaOH solution containing NaBH4 is extracted it twice to obtain two extracts. The two extracts are combined and an appropriate amount of glacial acetic acid are added for neutralization. The extracts are centrifugalized and precipitate is collected. After washing the precipitate with ultrapure water, the precipitate is dissolved with LiCl-DMSO. The precipitate that is insoluble in the LiCl-DMSO solution is dialyzed and freeze-dried to obtain the water-insoluble dietary fiber component ACA-IDK of Antrodia cinnamomea. The LiCl-DMSO solution is subjected to ethanol/DMSO fractional precipitation, and then the precipitate is collected and dialyzed. The water-insoluble dietary fiber component ACA-DK of Antrodia cinnamomea is obtained after freeze-drying.
A PREPARATION METHOD OF ANTRODIA CINNAMOMEA WATER-INSOLUBLE DIETARY FIBER
A preparation method of Antrodia cinnamomea water-insoluble dietary fiber. After ethanol and water extraction, Antrodia cinnamomea wastes are dried and superfine-comminuted to obtain Antrodia cinnamomea waste powder. The waste powder treated with NaOH solution containing NaBH4 is extracted it twice to obtain two extracts. The two extracts are combined and an appropriate amount of glacial acetic acid are added for neutralization. The extracts are centrifugalized and precipitate is collected. After washing the precipitate with ultrapure water, the precipitate is dissolved with LiCl-DMSO. The precipitate that is insoluble in the LiCl-DMSO solution is dialyzed and freeze-dried to obtain the water-insoluble dietary fiber component ACA-IDK of Antrodia cinnamomea. The LiCl-DMSO solution is subjected to ethanol/DMSO fractional precipitation, and then the precipitate is collected and dialyzed. The water-insoluble dietary fiber component ACA-DK of Antrodia cinnamomea is obtained after freeze-drying.
GENETIC ENGINEERING OF FUNGI TO MODULATE TRYPTAMINE EXPRESSION
Provided herein are methods for modulating the psilocybin biosynthesis pathway in fungi or other organisms. Also provided are genetically modified fungi and organisms with induced and/or increased expression of psilocybin and psilocin and psilocybin and/or psilocin compositions generated by the provided methods.
GENETIC ENGINEERING OF FUNGI TO MODULATE TRYPTAMINE EXPRESSION
Provided herein are methods for modulating the psilocybin biosynthesis pathway in fungi or other organisms. Also provided are genetically modified fungi and organisms with induced and/or increased expression of psilocybin and psilocin and psilocybin and/or psilocin compositions generated by the provided methods.
METHANOL-BASED EXTRACTION OF PSYCHOACTIVE ALKALOIDS FROM FUNGUS
This invention relates to the extraction of psychoactive compounds from fungus for use in medicine. Raw fungus is dried and ground. The solvent used for extraction is methanol or a hydro-methanol mixture, an acidic hydro-methanol mixture, or an alkaline hydro-methanol mixture. The extraction slurry is filtered and pH-adjusted if necessary. The methanol in the solvent is then completely evaporated and water added back, where necessary, to form a concentrated slurry. The concentrated slurry is then standardized to provide a known concentration of the psychoactive alkaloids that have been extracted. The standardized slurry may then be dried to result in a powdered extract with a precisely defined purity of psychoactive compounds.
METHANOL-BASED EXTRACTION OF PSYCHOACTIVE ALKALOIDS FROM FUNGUS
This invention relates to the extraction of psychoactive compounds from fungus for use in medicine. Raw fungus is dried and ground. The solvent used for extraction is methanol or a hydro-methanol mixture, an acidic hydro-methanol mixture, or an alkaline hydro-methanol mixture. The extraction slurry is filtered and pH-adjusted if necessary. The methanol in the solvent is then completely evaporated and water added back, where necessary, to form a concentrated slurry. The concentrated slurry is then standardized to provide a known concentration of the psychoactive alkaloids that have been extracted. The standardized slurry may then be dried to result in a powdered extract with a precisely defined purity of psychoactive compounds.
Nutritional Support Method For Health Issues
A method of improving the outcome or recovery for depression, diabetes, cardiovascular disease, Alzheimers progression, or breast cancer. This method consists of administering a food which includes transfer factor, lactic acid generating bacteria, and/or glucans in appropriate combinations and dosage levels. The food reduces cortisol levels, enhances the immune system, and balances hormones and cytokines. Dosage amounts are dependent on client weight. Consumption frequency and dosage may be adjusted. Typically, consumption of the food is done in combination with established medical treatments.
Nutritional Support Method For Health Issues
A method of improving the outcome or recovery for depression, diabetes, cardiovascular disease, Alzheimers progression, or breast cancer. This method consists of administering a food which includes transfer factor, lactic acid generating bacteria, and/or glucans in appropriate combinations and dosage levels. The food reduces cortisol levels, enhances the immune system, and balances hormones and cytokines. Dosage amounts are dependent on client weight. Consumption frequency and dosage may be adjusted. Typically, consumption of the food is done in combination with established medical treatments.